Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 5
2009 4
2010 2
2011 6
2012 1
2013 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.
Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF; Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries. Venkitachalam L, et al. Circ Cardiovasc Interv. 2009 Feb;2(1):6-13. doi: 10.1161/CIRCINTERVENTIONS.108.825323. Epub 2008 Dec 15. Circ Cardiovasc Interv. 2009. PMID: 20031687 Free PMC article.
Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry).
Parikh SV, Saya S, Divanji P, Banerjee S, Selzer F, Abbott JD, Naidu SS, Wilensky RL, Faxon DP, Jacobs AK, Holper EM. Parikh SV, et al. Am J Cardiol. 2011 Apr 1;107(7):959-64. doi: 10.1016/j.amjcard.2010.11.019. Epub 2011 Jan 20. Am J Cardiol. 2011. PMID: 21256469 Free PMC article.
Beneficial effects of statins after percutaneous coronary intervention.
Zhang ZJ, Marroquin OC, Weissfeld JL, Stone RA, Mulukutla SR, Williams DO, Selzer F, Kip KE. Zhang ZJ, et al. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):445-50. doi: 10.1097/HJR.0b013e32832a4e3b. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19369875 Free PMC article.
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry).
Green SM, Selzer F, Mulukutla SR, Tadajweski EJ, Green JA, Wilensky RL, Laskey WK, Cohen HA, Rao SV, Weisbord SD, Lee JS, Reis SE, Kip KE, Kelsey SF, Williams DO, Marroquin OC. Green SM, et al. Am J Cardiol. 2011 Dec 1;108(11):1658-64. doi: 10.1016/j.amjcard.2011.07.029. Epub 2011 Sep 3. Am J Cardiol. 2011. PMID: 21890077 Free PMC article. Clinical Trial.
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE. Mulukutla SR, et al. JACC Cardiovasc Interv. 2008 Apr;1(2):139-47. doi: 10.1016/j.jcin.2008.02.005. JACC Cardiovasc Interv. 2008. PMID: 19212456 Free PMC article.
17 results